Enlivex director reports initial share holdings

Enlivex Ltd. director Shai A. Novik filed an initial Form 3 reporting his beneficial ownership.

Accepted by SEC EDGAR 03/18/2026 - 07:08 AM EDT

(Moderate)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Enlivex Ltd. director Shai A. Novik filed an initial Form 3 reporting his beneficial ownership. He holds 6,974,017 Ordinary Shares, par value NIS 0.40 per share, directly. The filing also lists multiple option awards to buy additional ordinary shares at exercise prices between 2.6900 and 12.2300, with expirations from 2030-05-03 to 2033-12-31. This Form 3 records existing holdings and does not show new purchases or sales.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider NOVIK SHAI A

Role Director

Type	Security	Shares	Price	Value
Holding	Option (right to buy)	--	--	--
Holding	Option (right to buy)	--	--	--
Holding	Option (right to buy)	--	--	--
Holding	Option (right to buy)	--	--	--
Holding	Option (right to buy)	--	--	--
Holding	Option (right to buy)	--	--	--
Holding	Ordinary Shares, par value NIS 0.40 per share	--	--	--

Holdings: Option (right to buy) — 1,143,716 contracts (Direct); Ordinary Shares, par value NIS 0.40 per share — 6,974,017 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Enlivex (ENLV) Form 3 filing by Shai A. Novik show?

The Form 3 shows director Shai A. Novik’s initial reported holdings in Enlivex Ltd. It discloses 6,974,017 ordinary shares held directly, plus several option awards to acquire additional ordinary shares at preset exercise prices and future expiration dates, establishing his baseline beneficial ownership position.

How many Enlivex ordinary shares does Shai A. Novik report owning on Form 3?

Shai A. Novik reports direct ownership of 6,974,017 Ordinary Shares, par value NIS 0.40 per share. This figure represents his stated beneficial ownership of Enlivex’s ordinary equity, separate from any options that could convert into additional shares if exercised in the future.

What stock options are reported for Shai A. Novik in the Enlivex Form 3?

The filing lists several option grants to buy ordinary shares, including blocks over 145,237 shares at an exercise price of 6.2200 and 250,000 shares at 3.6600. Additional grants carry exercise prices up to 12.2300, with expirations extending through dates such as 2033-12-31.

Does the Enlivex (ENLV) Form 3 indicate any recent insider buying or selling?

The Form 3 does not show recent buying or selling activity. All entries are coded as holdings with unknown transaction codes, meaning the document serves to disclose existing share and option positions rather than report new market transactions or changes in ownership direction.

Why is Shai A. Novik’s Enlivex Form 3 important for investors?

This Form 3 establishes Shai A. Novik’s baseline ownership as a director of Enlivex Ltd. It details his 6,974,017 ordinary shares and multiple option positions, helping investors understand his equity exposure and long-term alignment with the company’s performance at the time of reporting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

NOVIK SHAI A

(Last)

(First)

(Middle)

14 EINSTEIN STREET

(Street)

NESS ZIONA

7403618

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Enlivex Ltd. [ ENLV ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares, par value NIS 0.40 per share	6,974,017	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Option (right to buy)	12/12/2021	12/31/2033	Ordinary Shares, par value NIS 0.40 per share	145,237	$6.22	D
Option (right to buy)	05/03/2023	05/03/2030	Ordinary Shares, par value NIS 0.40 per share	250,000	$3.66	D
Option (right to buy)	05/28/2024	05/28/2031	Ordinary Shares, par value NIS 0.40 per share	250,000	$12.23	D
Option (right to buy)	11/24/2025	11/17/2032	Ordinary Shares, par value NIS 0.40 per share	115,500	$5.34	D
Option (right to buy)	11/17/2025	11/17/2032	Ordinary Shares, par value NIS 0.40 per share	250,000	$5.34	D
Option (right to buy)	06/01/2019	12/31/2033	Ordinary Shares, par value NIS 0.40 per share	132,979	$2.69	D

Explanation of Responses:

Remarks:

See Exhibit 24.1 - Power of Attorney

	/s/ Shachar Shlosberger, Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR